220 related articles for article (PubMed ID: 26258658)
1. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
[TBL] [Abstract][Full Text] [Related]
2. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
Faraoni D; Rozen L; Willems A; Torres CS; Pereira LM; Demulder A; Van der Linden P
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):290-7. PubMed ID: 25806960
[TBL] [Abstract][Full Text] [Related]
3. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study.
Lechien A; Faraoni D; Van der Linden P
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):186-193. PubMed ID: 33470644
[TBL] [Abstract][Full Text] [Related]
4. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Fibrinolysis Using Velocity Curves Measured with Thromboelastometry in Children with Congenital Heart Disease.
Faraoni D; Van der Linden P; Ducloy-Bouthors AS; Goobie SM; DiNardo JA; Nielsen VG
Anesth Analg; 2015 Aug; 121(2):486-91. PubMed ID: 26049780
[TBL] [Abstract][Full Text] [Related]
6. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
Godier A; Parmar K; Manandhar K; Hunt BJ
J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
[TBL] [Abstract][Full Text] [Related]
8. Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients.
Yoshii R; Takahashi Y; Tanaka KA; Kawajiri H; Sawa T; Amaya F; Ogawa S
Br J Anaesth; 2024 Jun; 132(6):1211-1218. PubMed ID: 38677950
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid corrects fibrinolysis in the presence of acidemia in a swine model of severe ischemic reperfusion.
DeBarros M; Hatch Q; Porta CR; Salgar S; Izenberg S; DuBose J; Eckert M; Martin M
J Trauma Acute Care Surg; 2014 Mar; 76(3):625-32; discussion 632-3. PubMed ID: 24553528
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolysis in trauma patients: wide variability demonstrated by the Lysis Timer.
Roullet S; Weinmann L; Labrouche S; Gisbert-Mora C; Biais M; Revel P; Freyburger G
Scand J Clin Lab Invest; 2019; 79(1-2):136-142. PubMed ID: 30861350
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of primary hyperfibrinolysis and in vitro investigation of the inhibitory effects of tranexamic acid in a group of dogs with sarcomas - A pilot study.
Langhorn R; Poulsen MK; Heidemann PL; Bochsen L; Ritz C; Kristensen AT; Nielsen LN
Res Vet Sci; 2021 May; 136():472-477. PubMed ID: 33838456
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M
BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942
[TBL] [Abstract][Full Text] [Related]
14. Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.
Tran HT; Sørensen B; Rea CJ; Bjørnsen S; Ueland T; Pripp AH; Tjønnfjord GE; Holme PA
Haemophilia; 2014 May; 20(3):369-75. PubMed ID: 24251535
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A.
Hvas AM; Sørensen HT; Norengaard L; Christiansen K; Ingerslev J; Sørensen B
J Thromb Haemost; 2007 Dec; 5(12):2408-14. PubMed ID: 18034766
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid leads to paradoxical coagulation changes during cardiac surgery: a pilot rotational thromboelastometry study.
Sharma R; Letson HL; Smith S; Dobson GP
J Surg Res; 2017 Sep; 217():100-112. PubMed ID: 28602219
[TBL] [Abstract][Full Text] [Related]
17. Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.
Miszta A; Ahmadzia HK; Luban NLC; Li S; Guo D; Holle LA; Berger JS; James AH; Gobburu JVS; van den Anker J; de Laat B; Wolberg AS
J Thromb Haemost; 2021 Jan; 19(1):221-232. PubMed ID: 33001565
[TBL] [Abstract][Full Text] [Related]
18. The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro.
Yee BE; Wissler RN; Zanghi CN; Feng C; Eaton MP
Anesth Analg; 2013 Oct; 117(4):767-772. PubMed ID: 24023015
[TBL] [Abstract][Full Text] [Related]
19. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tissue-type plasminogen activator-evoked hyperfibrinolysis is enhanced by acidosis and inhibited by hypothermia but still can be blocked by tranexamic acid.
Dirkmann D; Radü-Berlemann J; Görlinger K; Peters J
J Trauma Acute Care Surg; 2013 Feb; 74(2):482-8. PubMed ID: 23354242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
